CBLL
CeriBell, Inc.
Price Chart
Latest Quote
$18.03
+0.75 (+4.34%)
Current Price
| Previous Close | $17.28 |
| Open | $17.63 |
| Day High | $18.07 |
| Day Low | $17.45 |
| Volume | 695,390 |
Stock Information
| Shares Outstanding | 37.94M |
| Total Debt | $22.12M |
| Cash Equivalents | $141.18M |
| Revenue | $95.07M |
| Net Income | $-60.37M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $684.11M |
| EPS (TTM) | $-1.62 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $560.87M |
| Sales | $95.07M |
| Income | $-60.37M |
| Book/sh | $3.72 |
| Cash/sh | $3.72 |
| Employees | 327 |
Financial Ratios
| Quick Ratio | 9.70 |
| Current Ratio | 10.44 |
| Debt/Eq | 15.71 |
Returns & Margins
| ROA | -20.73% |
| ROE | -37.53% |
| Gross Margin | 87.72% |
| Operating Margin | -78.30% |
| Profit Margin | -63.51% |
Ownership
| Insider Ownership | 12.88% |
| Institutional Ownership | 86.75% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -16.42 |
| P/S | 7.20 |
| P/B | 4.85 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $26.86 |
Technical Indicators
| SMA20 | $18.24 |
| SMA50 | $19.01 |
| SMA200 | $17.49 |
| RSI | 46.85 |
| ATR | 0.8382 |
| Shares Float | 25.85M |
| Short Float | 7.81% |
| Short Ratio | 5.59 |
| Rel Volume | 2.39 |
Performance History
| Week | -0.66% |
| Month | +6.31% |
| Quarter | -5.25% |
| 6 Months | -18.01% |
| YTD | -15.35% |
| Year | +1.63% |
| 10 Years | -27.88% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $18.03 | 708,900 |
| 2026-06-17 | $17.28 | 402,100 |
| 2026-06-16 | $17.92 | 206,300 |
| 2026-06-15 | $18.59 | 233,600 |
| 2026-06-12 | $18.47 | 209,700 |
| 2026-06-11 | $18.15 | 242,700 |
| 2026-06-10 | $18.38 | 251,500 |
| 2026-06-09 | $18.50 | 433,600 |
| 2026-06-08 | $18.14 | 277,800 |
| 2026-06-05 | $18.25 | 202,500 |
| 2026-06-04 | $18.75 | 347,400 |
| 2026-06-03 | $17.18 | 348,400 |
| 2026-06-02 | $17.50 | 262,500 |
| 2026-06-01 | $17.61 | 384,300 |
| 2026-05-29 | $18.45 | 179,600 |
| 2026-05-28 | $18.67 | 159,600 |
| 2026-05-27 | $18.70 | 122,200 |
| 2026-05-26 | $18.80 | 187,200 |
| 2026-05-22 | $18.77 | 204,300 |
| 2026-05-21 | $18.74 | 563,600 |
| 2026-05-20 | $18.10 | 350,900 |
| 2026-05-19 | $16.96 | 301,700 |
About CeriBell, Inc.
CeriBell, Inc. operates as a medical technology company in the United States. It develops the Ceribell System, a novel and point-of-care EEG platform specifically designed to address the unmet needs of patients in the acute care setting. The company also offers disposable, flexible headbands, and headcaps; and a pocket-sized, rechargeable battery-operated recorder used to capture and wirelessly transmit EEG signals; and Clarity, an AI-powered seizure detection algorithm. In addition, it operates an EEG portal, which enables real-time remote access to a patient's EEG data. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. CeriBell, Inc. was incorporated in 2014 and is headquartered in Sunnyvale, California.
đ° Latest News
CeriBell Sees âEarly Inningsâ Growth as Hospital Accounts and Usage Hit Records
MarketBeat âĸ 2026-05-15T05:07:03Z
CeriBell Inc (CBLL) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Market ...
GuruFocus.com âĸ 2026-05-12T07:07:12ZCeriBell Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-11T23:05:11Z
CeriBell (CBLL) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-11T22:07:08Z
CeriBell, Inc. (CBLL) Reports Q1 Loss, Beats Revenue Estimates
Zacks âĸ 2026-05-11T22:05:03Z
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates
Zacks âĸ 2026-05-06T22:30:04Z
Ceribell (CBLL) Rose 91% after Reporting Inline Financial Results
Insider Monkey âĸ 2026-04-02T13:43:45Z
CeriBell Conference: CFO Highlights 36% Revenue Growth, Expands EEG Platform to Pediatrics and Delirium
MarketBeat âĸ 2026-03-07T16:15:02Z
CeriBell Highlights 2026 Growth Plan at TD Cowen: 25%-29% Guide, VA Ramp, Delirium Pilot
MarketBeat âĸ 2026-03-07T15:23:13Z
Cautious Guidance Offsets Solid Q4 for CeriBell, Inc. (CBLL), Says Canaccord
Insider Monkey âĸ 2026-03-02T15:23:16Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $10,789,000 | $8,694,000 | $7,062,000 | $4,430,000 |
| Cost Of Revenue | $10,789,000 | $8,694,000 | $7,062,000 | $4,430,000 |
| Total Revenue | $89,063,000 | $65,444,000 | $45,225,000 | $25,922,000 |
| Operating Revenue | $89,063,000 | $65,444,000 | $45,225,000 | $25,922,000 |
| Expenses | ||||
| Interest Expense | $1,890,000 | $1,992,000 | $2,098,000 | $1,603,000 |
| Total Expenses | $147,465,000 | $105,153,000 | $75,266,000 | $61,943,000 |
| Other Income Expense | $6,880,000 | $1,246,000 | $2,686,000 | $462,000 |
| Other Non Operating Income Expenses | $6,880,000 | $2,742,000 | $2,638,000 | $637,000 |
| Net Non Operating Interest Income Expense | $-1,890,000 | $-1,992,000 | $-2,098,000 | $-1,603,000 |
| Interest Expense Non Operating | $1,890,000 | $1,992,000 | $2,098,000 | $1,603,000 |
| Operating Expense | $136,676,000 | $96,459,000 | $68,204,000 | $57,513,000 |
| Selling And Marketing Expense | $73,082,000 | $49,055,000 | $38,922,000 | $31,811,000 |
| General And Administrative Expense | $44,451,000 | $33,842,000 | $20,287,000 | $18,459,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Net Interest Income | $-1,890,000 | $-1,992,000 | $-2,098,000 | $-1,603,000 |
| Normalized Income | $-53,412,000 | $-38,959,000 | $-29,512,000 | $-36,989,000 |
| Net Income From Continuing And Discontinued Operation | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Total Operating Income As Reported | $-58,402,000 | $-39,709,000 | $-30,041,000 | $-36,021,000 |
| Net Income Common Stockholders | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Net Income | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Net Income Including Noncontrolling Interests | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Net Income Continuous Operations | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Pretax Income | $-53,412,000 | $-40,455,000 | $-29,453,000 | $-37,162,000 |
| Operating Income | $-58,402,000 | $-39,709,000 | $-30,041,000 | $-36,021,000 |
| Gross Profit | $78,274,000 | $56,750,000 | $38,163,000 | $21,492,000 |
| Per Share | ||||
| Diluted EPS | $-1.46 | $-3.39 | $-1.26 | $-1.59 |
| Basic EPS | $-1.46 | $-3.39 | $-1.26 | $-1.59 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-50,181,000 | $-35,826,000 | $-26,556,000 | $-34,887,000 |
| Reconciled Depreciation | $1,341,000 | $1,141,000 | $847,000 | $497,000 |
| EBITDA (Bullshit earnings) | $-50,181,000 | $-37,322,000 | $-26,508,000 | $-35,062,000 |
| EBIT | $-51,522,000 | $-38,463,000 | $-27,355,000 | $-35,559,000 |
| Diluted Average Shares | $36,542,048 | $11,949,973 | $23,324,240 | $23,324,240 |
| Basic Average Shares | $36,542,048 | $11,949,973 | $23,324,240 | $23,324,240 |
| Diluted NI Availto Com Stockholders | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Tax Provision | $0 | $0 | $11,000 | $2,000 |
| Research And Development | $19,143,000 | $13,562,000 | $8,995,000 | $7,243,000 |
| Selling General And Administration | $117,533,000 | $82,897,000 | $59,209,000 | $50,270,000 |
| Other Gand A | $44,451,000 | $33,842,000 | $20,287,000 | $18,459,000 |
| Total Unusual Items | - | $-1,496,000 | $48,000 | $-175,000 |
| Total Unusual Items Excluding Goodwill | - | $-1,496,000 | $48,000 | $-175,000 |
| Gain On Sale Of Security | - | $-1,496,000 | $48,000 | $-175,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $155,336,000 | $191,165,000 | $-112,252,000 | $-86,398,000 |
| Total Assets | $195,803,000 | $225,412,000 | $58,922,000 | $86,458,000 |
| Total Non Current Assets | $9,085,000 | $8,140,000 | $6,959,000 | $6,659,000 |
| Other Non Current Assets | $2,577,000 | $1,842,000 | $1,984,000 | $1,834,000 |
| Non Current Deferred Assets | $2,182,000 | $1,853,000 | $1,238,000 | $952,000 |
| Current Assets | $186,718,000 | $217,272,000 | $51,963,000 | $79,799,000 |
| Other Current Assets | $2,906,000 | $3,250,000 | $2,130,000 | $1,165,000 |
| Current Deferred Assets | $2,210,000 | $1,837,000 | $1,515,000 | $1,029,000 |
| Inventory | $7,288,000 | $6,937,000 | $5,868,000 | $4,075,000 |
| Receivables | $15,053,000 | $10,878,000 | $7,955,000 | $5,295,000 |
| Accounts Receivable | $15,053,000 | $10,878,000 | $7,955,000 | $5,295,000 |
| Cash Cash Equivalents And Short Term Investments | $159,261,000 | $194,370,000 | $34,495,000 | $68,235,000 |
| Cash And Cash Equivalents | $40,476,000 | $194,370,000 | $34,495,000 | $68,235,000 |
| Debt | ||||
| Total Debt | $22,276,000 | $21,960,000 | $14,204,000 | $18,220,000 |
| Long Term Debt And Capital Lease Obligation | $21,171,000 | $20,872,000 | $1,677,000 | $15,091,000 |
| Long Term Debt | $19,811,000 | $19,558,000 | - | $12,720,000 |
| Current Debt And Capital Lease Obligation | $1,105,000 | $1,088,000 | $12,527,000 | $3,129,000 |
| Current Debt | - | - | $11,833,000 | $2,500,000 |
| Other Current Borrowings | - | - | $11,833,000 | $2,500,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $40,467,000 | $34,247,000 | $171,174,000 | $172,856,000 |
| Total Non Current Liabilities Net Minority Interest | $21,277,000 | $21,258,000 | $149,574,000 | $162,992,000 |
| Other Non Current Liabilities | $106,000 | $356,000 | $441,000 | $489,000 |
| Non Current Deferred Liabilities | $0 | $30,000 | $44,000 | $0 |
| Current Liabilities | $19,190,000 | $12,989,000 | $21,600,000 | $9,864,000 |
| Other Current Liabilities | $818,000 | $609,000 | $595,000 | $146,000 |
| Current Deferred Liabilities | $101,000 | $97,000 | $206,000 | $343,000 |
| Payables And Accrued Expenses | $10,080,000 | $6,804,000 | $5,140,000 | $3,886,000 |
| Payables | $2,838,000 | $1,143,000 | $732,000 | $423,000 |
| Accounts Payable | $2,838,000 | $1,143,000 | $732,000 | $423,000 |
| Equity | ||||
| Common Stock Equity | $155,298,000 | $191,129,000 | $-112,252,000 | $-86,398,000 |
| Preferred Stock Equity | $38,000 | $36,000 | - | - |
| Total Equity Gross Minority Interest | $155,336,000 | $191,165,000 | $-112,252,000 | $-86,398,000 |
| Stockholders Equity | $155,336,000 | $191,165,000 | $-112,252,000 | $-86,398,000 |
| Gains Losses Not Affecting Retained Earnings | $159,000 | $0 | - | - |
| Other Equity Adjustments | $159,000 | - | - | - |
| Retained Earnings | $-220,356,000 | $-166,944,000 | $-126,489,000 | $-97,025,000 |
| Preferred Securities Outside Stock Equity | - | $0 | $147,412,000 | $147,412,000 |
| Other | ||||
| Ordinary Shares Number | $37,485,124 | $35,850,606 | $34,018,654 | $34,018,654 |
| Share Issued | $37,485,124 | $35,850,606 | $34,018,654 | $34,018,654 |
| Tangible Book Value | $155,298,000 | $191,129,000 | $-112,252,000 | $-86,398,000 |
| Invested Capital | $175,109,000 | $210,687,000 | $-100,419,000 | $-71,178,000 |
| Working Capital | $167,528,000 | $204,283,000 | $30,363,000 | $69,935,000 |
| Capital Lease Obligations | $2,465,000 | $2,402,000 | $2,371,000 | $3,000,000 |
| Total Capitalization | $175,147,000 | $210,723,000 | $-112,252,000 | $-73,678,000 |
| Additional Paid In Capital | $375,495,000 | $358,073,000 | $14,232,000 | $10,622,000 |
| Capital Stock | $38,000 | $36,000 | $5,000 | $5,000 |
| Common Stock | $0 | $0 | $5,000 | $5,000 |
| Preferred Stock | $38,000 | $36,000 | $0 | - |
| Non Current Deferred Revenue | $0 | $30,000 | $44,000 | $0 |
| Long Term Capital Lease Obligation | $1,360,000 | $1,314,000 | $1,677,000 | $2,371,000 |
| Current Deferred Revenue | $101,000 | $97,000 | $206,000 | $343,000 |
| Current Capital Lease Obligation | $1,105,000 | $1,088,000 | $694,000 | $629,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $7,086,000 | $4,391,000 | $3,132,000 | $2,360,000 |
| Current Accrued Expenses | $7,242,000 | $5,661,000 | $4,408,000 | $3,463,000 |
| Net PPE | $4,326,000 | $4,445,000 | $3,737,000 | $3,873,000 |
| Accumulated Depreciation | $-2,706,000 | $-1,692,000 | $-1,368,000 | $-860,000 |
| Gross PPE | $7,032,000 | $6,137,000 | $5,105,000 | $4,733,000 |
| Leases | $852,000 | $810,000 | $348,000 | $342,000 |
| Construction In Progress | $218,000 | $586,000 | $387,000 | $100,000 |
| Other Properties | $4,714,000 | $3,637,000 | $3,266,000 | $3,448,000 |
| Machinery Furniture Equipment | $1,248,000 | $1,104,000 | $1,104,000 | $843,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $2,303,000 | $2,843,000 | $2,463,000 | $2,039,000 |
| Raw Materials | $4,985,000 | $4,094,000 | $3,405,000 | $2,036,000 |
| Other Short Term Investments | $118,785,000 | $0 | - | - |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-41,575,000 | $-36,383,000 | $-30,142,000 | $-32,518,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-40,808,000 | $-35,043,000 | $-29,159,000 | $-32,002,000 |
| Cash Flow From Continuing Operating Activities | $-40,808,000 | $-35,043,000 | $-29,159,000 | $-32,002,000 |
| Operating Gains Losses | $104,000 | $1,591,000 | $133,000 | $273,000 |
| Investing Activities | ||||
| Capital Expenditure | $-767,000 | $-1,340,000 | $-983,000 | $-516,000 |
| Investing Cash Flow | $-118,137,000 | $-1,598,000 | $-1,763,000 | $-1,399,000 |
| Cash Flow From Continuing Investing Activities | $-118,137,000 | $-1,598,000 | $-1,763,000 | $-1,399,000 |
| Net Other Investing Changes | $-755,000 | $-258,000 | $-780,000 | $-883,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $192,834,000 | $0 | $50,000,000 |
| Financing Cash Flow | $5,051,000 | $196,516,000 | $-2,818,000 | $49,805,000 |
| Cash Flow From Continuing Financing Activities | $5,051,000 | $196,516,000 | $-2,818,000 | $49,805,000 |
| Net Other Financing Charges | $-386,000 | $-5,352,000 | - | - |
| Net Common Stock Issuance | $0 | $192,834,000 | $0 | - |
| Common Stock Issuance | $0 | $192,834,000 | $0 | - |
| Repurchase Of Capital Stock | - | - | $0 | $-310,000 |
| Net Preferred Stock Issuance | - | - | $0 | $49,690,000 |
| Preferred Stock Issuance | - | - | $0 | $50,000,000 |
| Other | ||||
| Issuance Of Debt | $0 | $7,905,000 | $0 | $0 |
| Interest Paid Supplemental Data | $1,894,000 | $1,952,000 | $1,734,000 | $1,628,000 |
| End Cash Position | $40,476,000 | $194,370,000 | $34,495,000 | $68,235,000 |
| Beginning Cash Position | $194,370,000 | $34,495,000 | $68,235,000 | $51,831,000 |
| Changes In Cash | $-153,894,000 | $159,875,000 | $-33,740,000 | $16,404,000 |
| Proceeds From Stock Option Exercised | $5,437,000 | $1,129,000 | $932,000 | $154,000 |
| Net Issuance Payments Of Debt | $0 | $7,905,000 | $-3,750,000 | $-39,000 |
| Net Long Term Debt Issuance | $0 | $7,905,000 | $-3,750,000 | $-39,000 |
| Long Term Debt Issuance | $0 | $7,905,000 | $0 | $0 |
| Net Investment Purchase And Sale | $-116,615,000 | $0 | - | - |
| Sale Of Investment | $94,200,000 | $0 | - | - |
| Purchase Of Investment | $-210,815,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-767,000 | $-1,340,000 | $-983,000 | $-516,000 |
| Purchase Of PPE | $-767,000 | $-1,340,000 | $-983,000 | $-516,000 |
| Change In Working Capital | $633,000 | $-3,172,000 | $-3,697,000 | $-3,884,000 |
| Change In Other Working Capital | $-26,000 | $-123,000 | $-93,000 | $95,000 |
| Change In Other Current Assets | $-415,000 | $-65,000 | $113,000 | $110,000 |
| Change In Payables And Accrued Expense | $5,968,000 | $2,719,000 | $2,475,000 | $2,119,000 |
| Change In Accrued Expense | $4,223,000 | $2,469,000 | $2,166,000 | $1,995,000 |
| Change In Payable | $1,745,000 | $250,000 | $309,000 | $124,000 |
| Change In Account Payable | $1,745,000 | $250,000 | $309,000 | $124,000 |
| Change In Prepaid Assets | $345,000 | $-1,121,000 | $-965,000 | $-347,000 |
| Change In Inventory | $-351,000 | $-1,068,000 | $-1,794,000 | $-1,902,000 |
| Change In Receivables | $-4,888,000 | $-3,514,000 | $-3,433,000 | $-3,959,000 |
| Changes In Account Receivables | $-4,175,000 | $-2,923,000 | $-2,660,000 | $-3,063,000 |
| Other Non Cash Items | $314,000 | $441,000 | $344,000 | $348,000 |
| Stock Based Compensation | $12,223,000 | $5,411,000 | $2,678,000 | $7,928,000 |
| Amortization Of Securities | $-2,011,000 | $0 | - | - |
| Depreciation Amortization Depletion | $1,341,000 | $1,141,000 | $847,000 | $497,000 |
| Depreciation And Amortization | $1,341,000 | $1,141,000 | $847,000 | $497,000 |
| Gain Loss On Sale Of PPE | $104,000 | $95,000 | $181,000 | - |
| Net Income From Continuing Operations | $-53,412,000 | $-40,455,000 | $-29,464,000 | $-37,164,000 |
| Repayment Of Debt | - | $0 | $-3,750,000 | $-39,000 |
| Long Term Debt Payments | - | $0 | $-3,750,000 | $-39,000 |
| Gain Loss On Investment Securities | - | $1,496,000 | $-48,000 | $175,000 |
| Preferred Stock Payments | - | - | $0 | $-310,000 |
Fetched: 2026-06-18